ADHD Pro
LibraryPRO Library
PRO Evidence Note

International ADHD Guideline Comparison: Commonalities and Differences

Result: Differences exist in specific recommendations across agencies/regions, making cross-referencing useful.

No previousNext pack
PRO Summary

How to read this card

Core signal

What: A 2023 review that comprehensively compared major international Clinical Guidelines including NICE, AAP, CADDRA, and SIGN.

Evidence scope

Who: Most guidelines include Non-Pharmacological Interventions (Parent Training, Behavioral Intervention) as a core strategy.

Use principle

Result: Differences exist in specific recommendations across agencies/regions, making cross-referencing useful.

Evidence Reading

What to check when interpreting the evidence

Study typeType: Systematic Review
PopulationPopulation: Children and Adolescents
EvidenceEvidence: Original Link (PMID:37313730)
UseResult: Differences exist in specific recommendations across agencies/regions, making cross-referencing useful.
Consultation Prep

Turn the card into questions before consultation

You can refer to the common emphasis on Parent Training across multiple guidelines.

Record this as a question or context point before professional consultation.

Recommendations may differ by country, so verify the context with a Korean professional.

Record this as a question or context point before professional consultation.

Limits

PRO use principles

Evidence scope

Limitation: This is a comparative review, not a guideline itself; referring to the original guideline documents is recommended.

Hold individual application

Do not transfer group-level findings, guideline summaries, or program effects directly to an individual case without considering fit, feasibility, and limits.

Use principle

Disclaimer: This information summarizes recent research findings and does not replace medical diagnosis or treatment. For health-related decisions, please consult a qualified professional.

Professional consultation

ADHD assessment, medication decisions, school support, and care planning should be discussed with a qualified professional.

Scope Note

Notice and limits

Limitation: This is a comparative review, not a guideline itself; referring to the original guideline documents is recommended.

Disclaimer: This information summarizes recent research findings and does not replace medical diagnosis or treatment. For health-related decisions, please consult a qualified professional.